|
TTC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.50459999998165E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.30690000008794E-07 |
| Normal-vs-Stage2 |
6.116300E-02 |
| Normal-vs-Stage3 |
8.734000E-02 |
| Normal-vs-Stage4 |
5.562000E-01 |
| Stage1-vs-Stage2 |
7.042000E-01 |
| Stage1-vs-Stage3 |
6.157000E-01 |
| Stage1-vs-Stage4 |
4.848200E-01 |
| Stage2-vs-Stage3 |
8.923600E-01 |
| Stage2-vs-Stage4 |
6.087600E-01 |
| Stage3-vs-Stage4 |
6.956600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51627999999127E-05 |
| Normal-vs-AfricanAmerican |
3.998700E-04 |
| Normal-vs-Asian |
5.096200E-01 |
| Caucasian-vs-AfricanAmerican |
8.864800E-01 |
| Caucasian-vs-Asian |
7.238000E-01 |
| AfricanAmerican-vs-Asian |
6.873800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00129999847098E-08 |
| Normal-vs-Female |
6.711200E-01 |
| Male-vs-Female |
2.957500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.980500E-04 |
| Normal-vs-Extreme_Weight |
8.3761000024829E-08 |
| Normal-vs-Obese |
1.789360E-01 |
| Normal-vs-Extreme_Obese |
3.88180000000515E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.452400E-01 |
| Normal_Weight-vs-Obese |
1.384840E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.328000E-01 |
| Extreme_Weight-vs-Obese |
7.755800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.694000E-01 |
| Obese-vs-Extreme_Obese |
9.587900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.861600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.562410E-03 |
| Normal-vs-Age(61-80Yrs) |
3.0919000026941E-08 |
| Normal-vs-Age(81-100Yrs) |
1.94287999999432E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.206780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.679900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.970130E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.493950E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.109600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.454400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.40340000001726E-06 |
| Normal-VS-Type2 PRCC |
2.15700002303976E-09 |
| Normal-VS-KIRP CIMP |
9.755900E-02 |
| Normal-VS-Unclassified PRCC |
3.616300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.386300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.141500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.826200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.056310E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.783950E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.376100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.05379999948418E-07 |
| Normal-vs-N1 |
9.560200E-01 |
| Normal-vs-N2 |
8.760600E-01 |
| N0-vs-N1 |
1.665730E-02 |
| N0-vs-N2 |
4.001000E-01 |
| N1-vs-N2 |
8.666600E-01 |
|
|
